{"schema_version":"secwatch.filing_event.v1","accession":"0001412408-23-000123","form_type":"8-K","ticker":"PHR","cik":"0001412408","company_name":"Phreesia, Inc.","filed_at":"2023-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.842960+00:00","generated_at":"2026-06-10T23:19:10.609979+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Phreesia reports Q2 FY2024 revenue $85.8M (+26% YoY); raises EBITDA outlook","bullets":["Revenue $85.8M vs $67.9M YoY (+26%); AHSCs 3,445 (+24% YoY).","Net loss $36.8M vs $46.7M YoY; adjusted EBITDA -$11.5M vs -$26.0M YoY.","Raises FY2024 adj. EBITDA outlook to -$54M to -$49M from -$60M to -$55M; revenue outlook unchanged $353M-$356M.","Acquired MediFind for ~$9M in June and Access eForms for $38.4M in August.","Payment processing revenue $23M (+21% YoY); take rate 2.91%, payment facilitator volume 82%."],"urls":{"canonical":"https://secwatch.observer/filing/0001412408-23-000123","json":"https://secwatch.observer/filing/0001412408-23-000123.json","markdown":"https://secwatch.observer/filing/0001412408-23-000123.md","text":"https://secwatch.observer/filing/0001412408-23-000123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412408/000141240823000123/0001412408-23-000123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412408/000141240823000123/phr-20230906.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T23:19:10.609979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"20beaa74df416be9cbcf7c1b3663281d1a68b293","claim":"Phreesia, Inc. reported fiscal quarter ended July 31, 2023 results: revenue $85.8 million, net income Net loss was $36.8 million. Guidance reaffirmed.","evidence_excerpt":"relations website at ir.phreesia.com to view the Company's Q2 Fiscal Year 2024 Stakeholder Letter. Fiscal Second Quarter Ended July 31, 2023 Highlights • Total revenue was $85.8 million in the quarter as compared to $67.9 million in the same period in the prior year, an increase of 26%. • Average number of healthcare services clients (\"AHSCs\") was 3,445 in the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1412408/000141240823000123/0001412408-23-000123-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal quarter ended July 31, 2023"},{"label":"Revenue","value":"$85.8 million"},{"label":"Net income","value":"Net loss was $36.8 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"a8e1dacde9b8f242a7f0dce16c5327aabb1b0d0c","claim":"Phreesia, Inc. updated its fiscal year 2024 ending January 31, 2024 guidance (reaffirmed).","evidence_excerpt":"We are maintaining our revenue outlook for the full fiscal year 2024 ending January 31, 2024 at between $353 million and $356 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1412408/000141240823000123/0001412408-23-000123-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2024 ending January 31, 2024"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}